HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Validation and comparison of the long-term prognostic capability of the SYNTAX score-II among 1,528 consecutive patients who underwent left main percutaneous coronary intervention.

AbstractOBJECTIVES:
This study sought to evaluate the long-term prognostic capacity of the SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score II (SS-II) and compare it with other risk scores among patients undergoing left main percutaneous coronary intervention (LM-PCI).
BACKGROUND:
Recently, the SS-II was developed in an attempt to individualize and help the decision-making process between PCI and coronary artery bypass graft (CABG) surgery in the management of complex coronary artery disease (CAD). However, there is a paucity of data regarding the utility of SS-II in patients undergoing LM-PCI.
METHODS:
Data from 1,528 consecutive patients from a single center undergoing unprotected LM-PCI were prospectively collected. The SS-II and other scores were then derived using patients' baseline clinical characteristics. Patients were stratified according to tertiles of SS-II for PCI: SS-II ≤21 (n = 508), SS-II >21 and ≤28 (n = 480), and >28 (n = 540). Predictive capability for long-term mortality was compared between angiographic scores and scores combining both angiographic and clinical variables.
RESULTS:
At a mean follow-up of 4.4 years, mortality in the first, second, and third SS-II tertiles was 1.8%, 3.5%, and 9.4%, respectively (p < 0.0001). Multivariate analysis showed SS-II to be a strong independent predictor of mortality (hazard ratio: 1.76, 95% confidence interval: 1.10 to 2.82; p = 0.02) after LM-PCI. When compared with the angiographic SS, scores combining both clinical and angiographic variables, such as the SS-II, were superior in terms of long-term prognostication.
CONCLUSIONS:
Results of this large series of consecutive patients who underwent unprotected LM-PCI suggested that the SS-II has better long-term prognostic power in terms of mortality compared with the original purely angiographic SS.
AuthorsBo Xu, Philippe Généreux, Yuejin Yang, Martin B Leon, Liang Xu, Shubin Qiao, Yongjian Wu, Hongbing Yan, Jilin Chen, Yelin Zhao, Yanyan Zhao, Tullio Palmerini, Gregg W Stone, Runlin Gao
JournalJACC. Cardiovascular interventions (JACC Cardiovasc Interv) Vol. 7 Issue 10 Pg. 1128-37 (Oct 2014) ISSN: 1876-7605 [Electronic] United States
PMID25240551 (Publication Type: Comparative Study, Journal Article, Validation Study)
CopyrightCopyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Topics
  • Adult
  • Aged
  • China
  • Coronary Angiography
  • Coronary Artery Disease (diagnostic imaging, mortality, physiopathology, therapy)
  • Coronary Vessels (diagnostic imaging)
  • Decision Support Techniques
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Percutaneous Coronary Intervention (adverse effects, mortality)
  • Predictive Value of Tests
  • Proportional Hazards Models
  • Prospective Studies
  • Reproducibility of Results
  • Risk Factors
  • Severity of Illness Index
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: